ABSTRAa. Bronchoalveolar macrophages (BAM) protect the adult lung from low level microbial contamination. The antimicrobial activity of human newborn BAM is unknown. BAM were isolated from effluents of suctioned, intubated newborns and from bronchoalveolar lavage of healthy, nonsmoking adult volunteers. An in vitro cytologic slide assay was developed and used to ascertain: 1 ) inhibition of intracellular filamentation of Candida albicans (active yeast growth) and 2) killing + digestion of ingested C. albicans. The ability to restrict intracellular yeast filamentation was markedly different for human newborn versus adult BAM. Adult BAM were five times more effective in restricting intracellular filamentation of Candida compared to newborn cells ( p c 0.01). Nonfilamented ingested yeast were also handled differently by newborn andadult macrophages. Nonfilamented yeast were killed and digested by adult BAM at a rate that was 2.5 times above that noted in neonatal lung macrophages ( p c 0.005).
The lung is the most common organ-specific site of nosocomial infections in pediatric patients (1). Neonates who develop bronchopulmonary dysplasia during their recovery from the respiratory distress syndrome are particularly susceptible to infectious pneumonia (2, 3) . Animal studies indicate that the adult lung has a fully established bronchoalveolar macrophage system that effectively clears the air spaces from microbial contamination compared to the neonate (4, 5) . Because no studies have examined the antimicrobial function of human newborn BAM, we report a technique that was able to use limited numbers of cells and ascertain the antixandida activity of neonatal lung macrophages compared to their adult counterparts.
METHODS
Patients. Fourteen preterm and 10 term infants requiring intubation and mechanical ventilation as part of their care at the UCLA Medical Center were the subjects of the newborn part of this study. Birth weight, gestational age, and relevant clinical diagnoses were based on data in the hospital record. Neonatal patients ranged from 3 days to 4 months of age at the time of study. No neonatal subjects had a diagnosis of acute bacterial infection of the lung when there were examined. Five healthy, nonsmoking volunteers (three male and two female, 27 + 7 yr) free of respiratory disease and drug or medication intake for the proceeding month, were the subject for the adult phase of this investigation.
Collection and preparation of bronchoalveolar macrophages.
Human newborn pulmonary macrophages were obtained from intubated infants by collecting material normally discarded as part of routine suctioning. Before suctioning, 0.25 ml of sterile, nonbacteriostatic saline was instilled into the endotracheal tube to facilitate removal of the tracheal debris. Suctioned material was collected into sterile specimen traps containing 10 ml of RPMI and 2 ml of 20% N-acetyl-L-cysteine solution (Mucomyst). The RPMI contained streptomycin (10,000 pg/ml) and penicillin (10,000 IU/ml) to inhibit bacterial growth. Material from three to five suctionings, over a 4-to 6-h period, was collected into a single specimen trap that was kept in an ice water bath. The collected material was filtered through two layers of sterile gauze to remove any large clumps of mucus, and spun at low speed (150 xg) to isolate a cell pellet. The supernatant was discarded and the cell pellet resuspended in BSH (6) . The cells were counted in a hemocytometer using 0.4% trypan blue in Dulbecco's phosphate-buffered saline as the diluent. Only specimens containing BAM having a viability 290% (trypan blue exclusion) were studied. The final concentration of cells was adjusted to 5 x lo6 viable BAM/ml.
After informed consent of the adult human subjects, their BAM were recovered by fiberoptic bronchoscopy and bronchoalveolar lavage as previously described (7) . The lavage effluent was centrifuged and the cell pellet resuspended in RPMI and kept in an ice water bath for 4-6 h. Thereafter, the cells were recentrifuged and suspended in BSH, counted (trypan blue exclusion r90%), and adjusted to a final concentration of 5 x lo6 viable BAM/ml. Therefore, except for the presence of Mucomyst the adult and newborn macrophages were processed in an identical manner. Protocols for these investigations were approved by our institutional review committee for studies involving human subjects.
Preparation of Candida. Candida albicans strain 820 was grown to log phase (16 h, 37" C) in Sabouraud 2% dextrose broth (Difco Laboratories, Detroit, MI). After washing by centrifugation in sterile normal saline, the resuspended yeast were held in an ice bath and sonicated with a microprobe (Biosonik IV, Bronwill, VWR Scientific, San Francisco, CA) at 70% power level for three 7-s intervals with 30-s rest periods between disruptions. The Candida were counted using sterile saline containing 0.0 1 % methylene blue. Methylene blue exclusion was used as a preliminary measure of yeast viability (299%) (8) .
In vitro anti-Candida assay. A total of 1 x lo5 (20 p1) cells from a newborn or adult suspension were mixed with 6.5 p1 of single donor adult human serum on specially prepared glass coverslips (9) . These round coverslips were held on a slide used for agglutination testing and placed inside a square Petri dish containing a gauze pad saturated with sterile water. The cells were allowed to adhere at 37" C for 60 min. After the adherence step, C. albicans (5 p1 ) was added at a BAM:Candida ratio of 2: 1. After a 30-min ingestion period, the coverslips were aspirated and replenished with 30 pl of BSH containing 20% adult human serum. The coverslips were incubated at 37" C for an additional 3.5 h, fixed in 95% methanol for 10 min, washed in deionized water, and stained with a 10% Giemsa solution. Our method is a variation of a slide assay that used the cytologic appearance of stained Candida within neonatal polymorphonuclear leukocytes to ascertain their killing and destruction (10). The coverslips were examined microscopically (1 000x) and 100 Candida ingested by BAM (those surrounded by cytoplasm and a halo of the phagolysosome) were scored according to the following criteria: 1 ) stained and filamented, 2) stained and unfilamented, 3) unstained and filamented, and 4) unstained and unfilamented (Fig. 1) . Microsco~ic assessment of macrovhages was limited to --those phagocytes containing 1-4 yeast because preliminary studies indicated that BAM were less effective in killing and digesting yeast during higher phagocytic load. During the Goring of ant: Candida activity, ingestion rates (number of BAM with intracellular Candida/ 100 BAM) and phagocytic profiles [number of intracellular yeast (0, 1, 2, 3, 4, > 4)/phagocytic macrophage] were determined. During scoring, extracellular yeast that remained on the coverslip after the 4-h incubation period were scored as filamented or nonfilamented.
Adult versus normal newborn animal studies. These studies were undertaken to ascertain: I) if BAM of animals produced findings similar to human neonates and adults and 2) if Mucomyst altered the microbicidal activity of these BAM. Twentyfour-hour-old (newborn, n = 7) and 4-month-old New Zealand albino rabbits (adults, n = 4, two of each sex), free of Bordetella bronchiseptica in the lower respiratory tract, were killed using either intracisternal injection of pentobarbital (25 mg/kg) or intravenous pentobarbital anesthesia (50 mg/kg) followed by an air embolus, respectively. The trachea was aseptically exposed, a sterile cannula was introduced and lung lavage was carried out as previously described (1 I). Lavage effluents were centrifuged and the recovered cell pellets were divided into two portions that were resuspended either in RPMI + Mucomyst (as above) or RPMI alone. These suspensions were kept on ice for 2 h. Thereafter, cells were pelleted by centrifugation (1 50 xg), resuspended in BSH, and quantitated. After the concentration was adjusted to 5 x lo6 BAM/ml, the cells were used in the in vitro antiCandida assay that was outlined in the previous section.
Animal hyperoxia experiment. This experiment was undertaken to determine if oxygen exposure could induce further defects in newborn rabbit macrophage anti-Candida activity, thereby duplicating the deficiencies seen in the human neonates. Neonatal rabbit alveolar macrophages were isolated by lavage (without Mucomyst) from animals reared for 96 h in 95 + % oxygen ( n = 8) or room air ( n = 8). These conditions of exposure have been previously described (12). The cells harvested from two animals within each group were mixed together in order to provide sufficient macrophage numbers for slide assays at time points 0, 1, 2, and 4 h. During data analysis, n = 4 was used as the number within each group (oxygen or room air), at each time point. Slide assays were scored as previously discussed.
Yeast kinetic analysis. The slide assays generated in the hyperoxia experiment were evaluated for the percent of extracellular yeast that were filamented (100 yeast counted/slide/time point) and for the percent of macrophages that were phagocytic (100 consecutive macrophages counted/slide/time point).
Data analysis. Anti-Candida activity of neonatal and adult groups was compared using the Mann-Whitney U test with correction for Bonferroni inequality. When more than one assay was performed on human newborns during their period of intubation, the values were averaged and treated as a single mean score for rank sum analyses. The two-tailed paired t test was used for animal studies that determined the effect of Mucomyst on the anti-Candida activity of the BAM. For data to be subjected to paired data analysis a probability plot of the data was first done to determine that the data was normally distributed. A statistical software package was used for these calculations (Systat, Systat Inc., Evanston, IL). Results are expressed as mean f SD. The significance level selected wasp < 0.05.
RESULTS
Patients. Gestational age of the human newborns from whom BAM were obtained ranged from 26-42 wk. Because our patients tended to be either very small premature infants or term neonates with congenital heart disease or pulmonary hypertension, the population was divided into a group under 1.2 kg [782 f 64 g (8/22), mean f SD (no. patientslno. samples)] and a group above 1.2 kg [2693 + 860 g (16/32)] for the purpose of data analysis. Three of the 16 subjects in the > 1.2 kg group were in the 1.2-2.0 kg range. Because their anti-Candida activity was similar to that reported in studies with larger newborns, they were included in the heavier weight category. Thirteen of the 24 neonates were studied at more than one time point. The list of clinical diagnoses for the two weight categories is shown in Table   1 1.
Human data. No differences were found in the ingestion rate of C. albicans by human newborn and adult BAM (< 1.2 kg = 29 + 11%, >1.2 kg = 29 f lo%, and adults = 40 f 17%, mean + SD). Ingestion profiles indicated that phagocytic newborn and adult BAM also had similar mean numbers of intracellular Candida (<1.2 kg = 1.7 f 0.1, >1.2 kg = 1.6 f 0.1, and adults = 1.8 + 0.2 ingested yeast/phagocytic BAM, mean + SD). Less than 3% of newborn and adult BAM had ingested >4 yeast/ phagocytic BAM.
Human BAM recovered from healthy adults were five times more effective in restricting the intracellular filamentation or growth of C. albicans when compared to BAM aspirated from the airways of sick newborns (Fig. 2) . This finding is in sharp contrast with the fact that >97% of extracellular C. albicans had germinated after 4 h under conditions of the assay. 8 6
Respiratory distress syndrome However, Figure 3 shows that human newborn and adult BAM did not differ in their overall ability to kill and digest C. albicans. The apparent disparity between the observation that newborn BAM could not restrict intracellular growth of Candida compared to adult BAM while they achieved a total killing and destruction rate equal to the adult BAM may be explained as follows. Human neonatal BAM destroyed filamented Candida twice as well as ungerminated organisms (Fig. 3) . Because approximately 50% of Candida ingested by neonatal lung macrophages germinated intracellularly, these phagocytes were able to destroy these fungi at a rate that was comparable to adult BAM. Adult BAM not only significantly restricted the intracellular growth of Candida (ca. 10% germinated intracellularly), but these mature phagocytes were twice as effective as neonatal BAM in killing and digesting ungerminated organisms (Fig. 3) . Thus overall, adult and newborn BAM had total percentages of killed and digested Candida that were equivalent.
Normal newborn and adult animal data. Studies using alveolar macrophages recovered from normal 1-day-old and adult rabbits concur with our human studies (Fig. 4) . Newborn rabbit BAM demonstrated substantially lower total killing and digestion, and increased yeast filamentation. In contrast to the human studies, both newborn and adult rabbit BAM demonstrated a reduced ability to kill and digest nonfilamented C. albicans versus fila- Hyperoxia experiment. There were no significant differences D' AMBOLA E T AL. Kinetic studies. Data for extracellular and total intracellular yeast filamentation are shown in Figure 5 . There was a profound difference in the percentage of filamented yeast between the intracellular and the extracellular compartments. Although extracellular yeast were unrestricted in their ability to grow (filamentation = 98 f 0.5% by 2 h), yeast ingested by macrophages from normal 4-day-old rabbits were limited to 33 + 13.5% filamentation (mean f SD, p < 0.05 by Mann-Whitney U test).
DISCUSSION
The method described here for the analysis of antifungal capacity of neonatal pulmonary macrophages has several unique advantages. Only a small number of cells is needed (minimum 1 x 105/coverslip). The cells can be obtained during routine tracheal suctioning; therefore, no special invasive procedures are required. The suctioned material from intubated newborns contains predominantly macrophages, but small numbers of neutrophils and epithelial cells are present. By allowing adherence to glass coverslips, we selected for the bronchoalveolar macrophage. Contaminating undesired cell types and uningested yeast were aspirated off the coverslip after the adherence and ingestion period. Inasmuch as only ingested Candida were counted in the assay, the presence of other mononuclear cells capable of glass adherence, but not phagocytosis, did not affect the results. The presence of lymphocytes was noted only occasionally, and the Candida ingested by the rarely seen polymorphonuclear leukocyte were easily recognized, but not included in the scoring.
Although our samples may have contained macrophages mainly from the larger airways, we believed it was unethical to lavage the lungs of ill neonates to obtain a higher yield of deep alveolar cells. Certainly, some of the cells under study were exiting the lung from more distal air spaces.
In general, during the first 3 days of life, the number of cells obtained was insufficient for analysis although the required amount could be recovered in a few infants. This finding is consistent with the known increase in the number of pulmonary macrophages that occurs in the first few weeks of life (13, 14). Initially, Mucomyst was not used during the collection of the macrophages; however, it soon became obvious that mucus was entrapping the lung macrophages, resulting in low cell yield. In the animal studies we found that Mucomyst had no detrimental effect on the slide assay results. However, its inclusion in the RPMI during specimen collection greatly enhanced cell yield. The use of normal adult serum allowed the neonatal cells to function optimally by supplying adequate amounts of opsonic factors known to be essential for phagocytosis (1 5). Previously, neonatal neutrophils have been shown to exhibit a defect in phagocytosis when neonatal serum was used as a source of opsonins; this defect was correctable by the use of adult serum (16) . The use of a standard adult serum allowed us to focus on the microbicidal activity of the BAM themselves.
The finding that neonatal pulmonary macrophages were, on the whole, able to kill and destroy ingested C. albicans at a rate equal to adult BAM was unexpected. However, this finding was due to the fact that Candida entered a phase of active growth inside the neonatal BAM which rendered the yeast more susceptible to destruction. Adult human BAM effectively restricted filamentation, and killed and digested yeast regardless of their growth state within the phagocyte. However, unless intracellular growth had occurred, neonatal cells were not as effective in killing and digesting yeast. Our assay method is a modification of the tumbling and slide assays of Lehrer and associates (8, 10 ).
In the assay described here, C. albicans were in log phase (16 h of incubation) rather than a stationary phase of growth (48 h to 14 days of incubation) as reported with prior analytical methods. When older yeast are used for the assay, there is a prolonged period before they filament within phagocytes (17) . C. albicans that are metabolically active and growing are killed more readily by nonoxidative effectors, namely cationic microbicidal peptides of rabbit and human phagocytes (18, 19) . In vitro exposure of log phase and stationary phase Candida to hydrogen peroxide also reveal the younger yeast are more easily inactivated (Sherman M, Lehrer R, unpublished observations).
Using BAM recovered from I-, 7-, and 28-day-old rabbits and a slide assay similar to our own, Zeligs et al. (20) reported that neonates may be prone to C. albicans infections because l-dayold lung macrophages have a candidacidal defect. Human monocytes and BAM kill this opportunistic organism via 02-dependent and 02-independent mechanisms (2 1, 22). The relative contribution of each mechanism to Candida killing by human newborn BAM is unknown. Studies using neonatal BAM of rabbits have indicated that these cells have a reduced resviratorv burst (02-dependent killing) and lower concentrations bf lyso~omal cbmponents (02-independent killing) than their adult counterparts (1 1, [23] [24] [25] . The normal 1-day-old and adult rabbit BAM data support the concept that newborn rabbit lung macrophages have a developmental abnormality in microbicidal function. However, one cannot conclude that diminished microbicidal mechanisms with the human neonatal BAM are totally explained by matuand drug treatment (27, 28) , may have caused the fungistatic defect noted in the human neonatal BAM. The data generated in the hyperoxia experiment, however, support the conclusion that oxygen exposure may be a principal agent in reducing fungistatic activity seen in the intubated human neonates. The newborn rabbit pups differed only in their oxygen exposure (room air versus 95% + 02) thereby removing the factors of positive pressure ventilation, intubation, drugs, and chronic lung disease. Pulmonary macrophages from oxygen-exposed animals demonstrated markedly diminished capacity to restrict intracellular yeast filamentation, and this finding is consistent with the adverse effects of oxygen exposure on the ability of the newborn rabbit BAM to kill ingested staphylococci (12).
Although total killing and digestion of yeast were similar in human neonates and adults, with similar findings in our animal experiments, the importance of intracellular yeast growth should not be ignored. Growing (filamenting) Candida were frequently seen to puncture the macrophage cell membrane. Such an occurrence would be expected to result in cell damage and death. Inasmuch as the process of microbial surveillance and defense is a dynamic one, the loss of a portion of the resident alveolar macrophage pool would be expected to result in diminished in vivo yeast clearance. Yeast whose intracellular germination had resulted in macrophage death would be released to the extracellular environment where reproduction would then continue.
It is entirely possible that BAM of healthy human newborns might function like normal adult lung macrophages, and BAM of ill, intubated adults might demonstrate the same abnormalities observed in the human neonatal cells in this study. The assay system described here may be useful in future studies as a means of delineating factors that make intubated patients highly susceptible to nosocomial pneumonia.
We conclude that the BAM recovered from intubated newborn infants undergoing intensive care have reduced capacity to restrict the intracellular growth of C. albicans. Oxygen therapy may be an important factor underlying this reduced fungistatic capacity.
